BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27241104)

  • 1. Lynch Syndrome: Female Genital Tract Cancer Diagnosis and Screening.
    Mills AM; Longacre TA
    Surg Pathol Clin; 2016 Jun; 9(2):201-14. PubMed ID: 27241104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory Assays in Evaluation of Lynch Syndrome in Patients with Endometrial Carcinoma.
    Djordjevic B; Broaddus RR
    Surg Pathol Clin; 2016 Jun; 9(2):289-99. PubMed ID: 27241109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lynch Syndrome Screening in the Gynecologic Tract: Current State of the Art.
    Mills AM; Longacre TA
    Am J Surg Pathol; 2016 Apr; 40(4):e35-44. PubMed ID: 26872009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review.
    Yokoyama T; Takehara K; Sugimoto N; Kaneko K; Fujimoto E; Okazawa-Sakai M; Okame S; Shiroyama Y; Yokoyama T; Teramoto N; Ohsumi S; Saito S; Imai K; Sugano K
    BMC Cancer; 2018 May; 18(1):576. PubMed ID: 29783979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?
    Kahn RM; Gordhandas S; Maddy BP; Baltich Nelson B; Askin G; Christos PJ; Caputo TA; Chapman-Davis E; Holcomb K; Frey MK
    Cancer; 2019 Sep; 125(18):3172-3183. PubMed ID: 31150123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor site discordance in mismatch repair deficiency in synchronous endometrial and ovarian cancers.
    Kim SR; Tone A; Kim R; Cesari M; Clarke B; Eiriksson L; Hart T; Aronson M; Holter S; Lytwyn A; Maganti M; Oldfield L; Gallinger S; Bernardini MQ; Oza AM; Djordjevic B; Lerner-Ellis J; Van de Laar E; Vicus D; Pugh TJ; Pollett A; Ferguson SE
    Int J Gynecol Cancer; 2020 Dec; 30(12):1951-1958. PubMed ID: 33082239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mismatch repair deficiency testing in clinical practice.
    Buza N; Ziai J; Hui P
    Expert Rev Mol Diagn; 2016; 16(5):591-604. PubMed ID: 26895074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Analysis of Clinical, Surgical, Pathological and Molecular Characteristics of Endometrial Cancer According to Mismatch Repair Status. A Multidisciplinary Approach.
    Dondi G; Coluccelli S; De Leo A; Ferrari S; Gruppioni E; Bovicelli A; Godino L; Coadă CA; Morganti AG; Giordano A; Santini D; Ceccarelli C; Turchetti D; De Iaco P; Perrone AM
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future role of genetic screening in gynecologic malignancies.
    Ring KL; Garcia C; Thomas MH; Modesitt SC
    Am J Obstet Gynecol; 2017 Nov; 217(5):512-521. PubMed ID: 28411145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70years of age.
    Goverde A; Spaander MC; van Doorn HC; Dubbink HJ; van den Ouweland AM; Tops CM; Kooi SG; de Waard J; Hoedemaeker RF; Bruno MJ; Hofstra RM; de Bekker-Grob EW; Dinjens WN; Steyerberg EW; Wagner A;
    Gynecol Oncol; 2016 Dec; 143(3):453-459. PubMed ID: 27789085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers.
    Kim SR; Tone A; Kim R; Cesari M; Clarke B; Hart T; Aronson M; Holter S; Lytwyn A; Maganti M; Oldfield L; Gallinger S; Bernardini MQ; Oza AM; Djordjevic B; Lerner-Ellis J; Van de Laar E; Vicus D; Pugh TJ; Pollett A; Ferguson SE; Eiriksson L
    Int J Gynecol Cancer; 2022 Jul; 32(7):891-898. PubMed ID: 35012974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic Gynecologic Specimens from Hereditary Cancer Carriers.
    Shaw PA; Clarke BA
    Surg Pathol Clin; 2016 Jun; 9(2):307-28. PubMed ID: 27241111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite instability analysis for the screening of synchronous endometrial and ovarian cancer in Lynch syndrome.
    Bats AS; Roussel H; Narjoz C; Le Frere-Belda MA; Chamming's F; Blons H; Laurent-Puig P; Lecuru F
    Anticancer Res; 2013 Sep; 33(9):3977-81. PubMed ID: 24023337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
    Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
    Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
    Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
    Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Muir-Torre syndrome--a phenotypic variant of Lynch syndrome].
    Kacerovská D; Kazakov DV; Cerná K; Hadravský L; Michal M; Dostál J; Skálová A; Michal M
    Cesk Patol; 2010 Oct; 46(4):86-94. PubMed ID: 21313735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simplified identification of Lynch syndrome: a prospective, multicenter study.
    Bonnet D; Selves J; Toulas C; Danjoux M; Duffas JP; Portier G; Kirzin S; Ghouti L; Carrère N; Suc B; Alric L; Barange K; Buscail L; Chaubard T; Imani K; Guimbaud R
    Dig Liver Dis; 2012 Jun; 44(6):515-22. PubMed ID: 22480969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of mismatch repair deficiency in ovarian cancer.
    Crosbie EJ; Ryan NAJ; McVey RJ; Lalloo F; Bowers N; Green K; Woodward ER; Clancy T; Bolton J; Wallace AJ; McMahon RF; Evans DG
    J Med Genet; 2021 Oct; 58(10):687-691. PubMed ID: 32917768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
    Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA
    Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome.
    Mas-Moya J; Dudley B; Brand RE; Thull D; Bahary N; Nikiforova MN; Pai RK
    Hum Pathol; 2015 Nov; 46(11):1616-25. PubMed ID: 26319271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.